0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

Racial/Ethnic Disparities in Prevalence, Treatment, and Control of Hypertension—United States, 1999-2002 FREE

JAMA. 2005;293(8):923-925. doi:10.1001/jama.293.8.923.
Text Size: A A A
Published online

RACIAL/ETHNIC DISPARITIES IN PREVALENCE, TREATMENT, AND CONTROL OF HYPERTENSION—UNITED STATES, 1999-2002

MMWR. 2005;54:7-9

1 table omitted

High blood pressure (HBP) is a major risk factor for heart disease and stroke, end-stage renal disease, and peripheral vascular disease and is a chief contributor to adult disability.1 Approximately one in four adults in the United States has hypertension.2 Although effective therapy has been available for more than 50 years,3 most persons with hypertension do not have their blood pressure (BP) under control.4 National health objectives for 2010 include reducing the proportion of adults with HBP to 16% (baseline: 28%), increasing the proportion of adults with hypertension who are taking action to control it to 95% (baseline: 82%), and increasing the proportion of adults with controlled BP to 50% (baseline: 18%).5 During 1990-2000, the prevalence of hypertension, the percentage of those with hypertension who were aware of their condition, and treatment and control of hypertension increased among non-Hispanic whites, non-Hispanic blacks, and Hispanics.6,7 CDC analyzed data from the National Health and Nutrition Examination Surveys (NHANES) for 1999-2002. This report summarizes the results of that analysis, which determined that racial/ethnic disparities in awareness of, treatment for, and control of hypertension persist. If national health objectives are to be met, public health efforts must continue to focus on the prevention of HBP and must improve awareness, treatment, and control of hypertension among minority populations.

NHANES is a stratified, multistage probability sample of the civilian, noninstitutionalized U.S. population. Both the survey interview population of 7,000 U.S. adults aged ≥20 years and the 5,000 respondents who completed the health examination each year included oversamples of low-income persons, persons aged ≥60 years, blacks, and Mexican Americans. The analysis described in this report is based on data from those persons who were non-Hispanic white, non-Hispanic black, or Mexican American with BP measurements. Pregnant women were excluded from the analysis. Hypertension was defined as having an average systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg or taking BP medication. BP measures were based on the average of three BP readings. Persons with hypertension were considered (1) to be aware of their condition if they reported in the interview that a health-care professional had told them their BP was high, 2) to have been treated if they reported using antihypertensive medication, and (3) to have controlled BP if they were hypertensive but their BP measurements were <140/90 mm Hg. Statistical software was used to obtain weighted population estimates, age-specific and age-standardized prevalences and proportions, and 95% confidence intervals (CIs).

During 1999-2002, the age-adjusted prevalence of hypertension in the study population was 28.6% (CI = 26.8%-30.4%). The prevalence of hypertension increased with age and was higher among women than men. The age-adjusted prevalence of hypertension was 40.5% among non-Hispanic blacks, 27.4% among non-Hispanic whites, and 25.1% among Mexican Americans. Of those with HBP, 63.4% (CI = 59.4%-67.4%) had been told that their BP was high. The proportion who were aware of having a high BP was greater among those aged ≥40 years (73.5% versus 48.7%), and the proportion was higher among women than men (69.3% versus 59.4%). Among adults with hypertension, the proportion who were aware of having HBP was 70.3% among non-Hispanic blacks, 62.9% among non-Hispanic whites, and 49.8% among Mexican Americans. Among those with hypertension, 45.3% (CI = 45.3%-52.8%) had been treated with antihypertensive medication. Percentages of those treated for HBP were higher among women than men (56.1% versus 45.2%) and increased with age. The age-adjusted proportion who reported treatment was 55.4% among non-Hispanic blacks, 48.6% among non-Hispanic whites, and 34.9% among Mexican Americans. Only 29% of U.S. adults with hypertension had controlled BP levels (<140/90 mm Hg), and the proportion of hypertensive adults who had controlled their BP varied substantially by age group: 17.6% of those aged 20-39 years, 40.5% of those aged 40-59 years, and 31.4% of those aged ≥60 years. The proportion with controlled BP was similar among non-Hispanic blacks (29.8%) and non-Hispanic whites (29.8%) but substantially lower among Mexican Americans (17.3%).

Reported by:

MJ Glover, ScD, KJ Greenlund, PhD, C Ayala, PhD, JB Croft, PhD, Div of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.

CDC Editorial Note:

The findings of this report demonstrate continuing racial/ethnic disparities in the prevalence of hypertension and in the percentages of those with HBP who are aware of, are being treated for, and are in control of their condition. Because of the serious health consequences associated with HBP, greater efforts are needed to prevent HBP and/or improve BP control and HBP diagnosis rates among all populations. Greater efforts are needed specifically to prevent HBP among non-Hispanic blacks, who have a higher prevalence, and to increase BP treatment and control among Mexican Americans, who appear to have lower rates of treatment and control, compared with other racial/ethnic populations. For this report, CDC analyzed a 4-year period instead of the 2-year period represented in data published recently from 1999-2000 NHANES7,8; therefore, this report also represents an update of those findings.

During 1991-1999, nearly 95% of U.S. adults had had a BP screening within the previous 2 years; however, levels of BP screening were lower among Hispanics than among non-Hispanic whites or non-Hispanic blacks.6 Lack of access to health-care services, insufficient attention by health-care providers, lack of necessary resources to engage in appropriate lifestyle modifications, cultural norms, and compliance in medication use might be barriers to prevention and control of HBP.

The findings in this report are subject to at least four limitations. First, NHANES only surveyed the noninstitutionalized population; persons in nursing homes and other institutions were not included. Second, Mexican Americans were the only Hispanic subpopulation sampled, even though the Hispanic population consists of only 66.1% Mexican Americans9; information for the other Hispanic subpopulations was not of sufficient size for reliable analysis. Third, although a strength of NHANES is the collection of actual BP measurements, these measurements are taken during the same visit and therefore do not reflect the actual care guidelines, which state that the determination of HBP should be based on measurements from two separate visits. Finally, analyses were restricted to NHANES participants who had BP measurements and do not include those who might have hypertension but did not have BP measurements.

The prevention and management of HBP is a major public health challenge. HBP usually has no signs or symptoms and is called “the silent killer.” Untreated or uncontrolled HBP increases risk for heart disease, renal disease, and stroke. Recommendations by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure advise health-care providers regarding screening, detecting, treating, and monitoring cases of HBP and hypertension.3 In addition, BP surveillance data should be used to monitor and evaluate the effectiveness of interventions designed to prevent and control HBP. To reduce disparities and improve HBP prevention and control among U.S. adults, public health officials and clinicians need to increase their efforts to treat and control BP levels among persons with hypertension, and promote physical activity, nutrition changes (e.g., reducing high salt/sodium), weight reduction or management, stress reduction, and routine BP screening.

REFERENCES
US Department of Health and Human Services; National Institutes for Health, National Heart, Lung, and Blood Institute.  High blood pressure: who is at risk? Available at http://www.nhlbi.nih.gov/health/dci/Diseases/Hbp/HBP_WhoIsAtRisk.html
American Heart Association.  Heart disease and stroke statistics—2004 update. Dallas, TX: American Heart Association; 2003
National High Blood Pressure Education Program.  The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  Hypertension. 2003;42:1206-1252
PubMed   |  Link to Article
Chobanian AV, Bakris GL, Black HR.  et al.  The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.  JAMA. 2003;289:2560-2572
Link to Article
US Department of Health and Human Services.  Healthy people 2010 (conference ed, in 2 vols). Washington, DC: US Department of Health and Human Services; 2000. Available at http://www.health.gov/healthypeople
CDC.  State-specific trends in self-reported blood pressure screening and high blood pressure—United States, 1991-1999.  MMWR. 2002;51:456-460
Fields LE, Burt VL, Cutler JA.  et al.  The burden of adult hypertension in the United States 1999 to 2000: a rising tide.  Hypertension. 2004;44:1-7
PubMed   |  Link to Article
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.  JAMA. 2003;290:199-206
PubMed   |  Link to Article
Ramirez RR, de la Cruz GP. The Hispanic population in the United States: March 2002. Curr Popul Rep [Spec Censuses]. 2002; P20-545

Figures

Tables

References

US Department of Health and Human Services; National Institutes for Health, National Heart, Lung, and Blood Institute.  High blood pressure: who is at risk? Available at http://www.nhlbi.nih.gov/health/dci/Diseases/Hbp/HBP_WhoIsAtRisk.html
American Heart Association.  Heart disease and stroke statistics—2004 update. Dallas, TX: American Heart Association; 2003
National High Blood Pressure Education Program.  The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  Hypertension. 2003;42:1206-1252
PubMed   |  Link to Article
Chobanian AV, Bakris GL, Black HR.  et al.  The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.  JAMA. 2003;289:2560-2572
Link to Article
US Department of Health and Human Services.  Healthy people 2010 (conference ed, in 2 vols). Washington, DC: US Department of Health and Human Services; 2000. Available at http://www.health.gov/healthypeople
CDC.  State-specific trends in self-reported blood pressure screening and high blood pressure—United States, 1991-1999.  MMWR. 2002;51:456-460
Fields LE, Burt VL, Cutler JA.  et al.  The burden of adult hypertension in the United States 1999 to 2000: a rising tide.  Hypertension. 2004;44:1-7
PubMed   |  Link to Article
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.  JAMA. 2003;290:199-206
PubMed   |  Link to Article
Ramirez RR, de la Cruz GP. The Hispanic population in the United States: March 2002. Curr Popul Rep [Spec Censuses]. 2002; P20-545
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Scenario

Users' Guides to the Medical Literature
Example 1: Diabetes and Target Blood Pressure